|By Business Wire||
|March 31, 2014 03:00 AM EDT||
The new FDA Roadmap App from PHT Corporation helps sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials released by the FDA with their Clinical Outcome Assessment Qualification Program. The program and roadmap highlight the process by which sponsors should consider, choose and/or develop clinical program patient-focused outcome measurement strategies. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.
The FDA Roadmap app optimizes the roadmap for Android phones and tablets. See it and download the Android app: http://www.phtcorp.com/Resources/Apps/FDA-Roadmap-App.aspx or download it via Google Play: http://bit.ly/PHTs-FDA-Roadmap-Android
The Roadmap helps trial sponsors improve clinical research that collects patient data through understanding the disease or condition, conceptualizing the treatment benefit resulting in identification of the targeted context of use (COU), and concept of interest (COI) for future clinical trial measurement.
PHT Vice President of Marketing and Product Management Sheila Rocchio said, “Clinical trials are including more patient reported outcomes (PROs) since the publication of the FDA Patient Reported Outcome (PRO) Guidance, The new app helps clinical research professionals quickly and easily reference roadmap content.”
The FDA Roadmap App exemplifies PHT innovation in mobile technology for clinical research. The PHT LogPad® System which collects compliant patient data using smartphones has been a finalist for the Clinical Informatics News Best Practices and SCDM Data Driven Innovation awards.
Learn about the latest PRO and eCOA innovations, case studies and best practices at the 2014 PRO & eCOA Congress: bit.ly/CongressBarcelona. Learn more about the PRO & eCOA Congress in one minute: http://bit.ly/1h39AHS
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter, Google+ and YouTube.